Remdesivir
Showing 1 - 25 of 256
COVID-19 Patients Requiring Hemodialysis
Completed
- Covid19
- End Stage Renal Failure on Dialysis
- Remdesivir
-
Budapest, HungarySemmelweis University - Department of Internal Medicine and Onco
Nov 8, 2022
SARS-CoV-2 Infection, COVID-19 Trial in Derby (Remdesivir)
Not yet recruiting
- SARS-CoV-2 Infection
- COVID-19
- Remdesivir
-
Derby, United KingdomUniversity of Derby
Jun 21, 2023
COVID-19 Trial in Mansoura (Casirivimab and Imdevimab Drug Combination, Remdesivir, Favipiravir)
Completed
- COVID-19
- Casirivimab and Imdevimab Drug Combination
- +2 more
-
Mansoura, El-dkhalia, EgyptEl-gomhoria St
Aug 13, 2022
OBSERVATIONAL STUDY OF COMPARISON EFFECTIVITY BETWEEN REMDESIVIR
Completed
- Duration of Hospitalization
- Clinical Manifestation of COVID-19
- Remdesivir
-
Surabaya, East Java, IndonesiaGotong Royong Surabaya Hospital
Jan 23, 2022
Covid19 Trial in Helsinki (Remdesivir)
Recruiting
- Covid19
- Remdesivir
-
Helsinki, FinlandUniversity of Helsinki
Jul 12, 2022
COVID Trial in Tanta (Remdesivir, Standard of care treatment)
Completed
- COVID
- Remdesivir
- Standard of care treatment
-
Tanta, EgyptTanta university hospital, Assuit University, Ainshams Universit
Jul 29, 2021
Ebola, HIV/AIDS Trial in Kampala (Remdesivir)
Completed
- Ebola
- HIV/AIDS
- Remdesivir
-
Kampala, UgandaInfectious Diseases Institute
Aug 19, 2021
COVID-19 Trial in Halifax (Baricitinib (janus kinase inhibitor), Remdesivir (antiviral) + barictinib (janus kinase inhibitor),
Recruiting
- COVID-19
- Baricitinib (janus kinase inhibitor)
- +3 more
-
Halifax, Nova Scotia, CanadaNova Scotia Health Authority
Mar 9, 2022
COVID-19 Trial in Budapest (Extracorporeal photopheresis)
Recruiting
- COVID-19
- Extracorporeal photopheresis
-
Budapest, HungarySouth Pest Central Hospital, National Institute of Haematology a
May 28, 2023
Covid19 Trial in Dhaka (Remdesivir, Standard of Care)
Completed
- Covid19
- Remdesivir
- Standard of Care
-
Dhaka, BangladeshCombined Military Hospital
Aug 9, 2021
COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)
Recruiting
- COVID-19
- Hospitalized COVID-19 Patients
- Lopinavir / Ritonavir
- +3 more
-
Zgharta, North, Lebanon
- +1 more
Jun 28, 2023
COVID-19 International Drug Pregnancy Registry
Recruiting
- Covid19
- Antiviral Agents
- Monoclonal antibody
-
Los Angeles, CaliforniaPregistry
Jul 20, 2022
Covid19 Trial in Bani Suwayf (Remdesivir, Lopinavir/ Ritonavir and Remdesivir combination)
Recruiting
- Covid19
- Remdesivir
- Lopinavir/ Ritonavir and Remdesivir combination
-
Banī Suwayf, EgyptBeni-suef University
Mar 15, 2021
Researchers at UC San Diego Are Learning About Benefits of Human
Recruiting
- Breastfeeding
- +4 more
- COVID-19 Exposure
- Antibiotic
-
San Diego, CaliforniaUniversity of California, San Diego
Sep 21, 2022
Antiviral Drugs on the Treatment of SARS-CoV-2
Recruiting
- Complication of Medical Care
- Pneumonia, Viral
- Favipiravir
- Remdesivir
-
Nur-Sultan, Kazakhstan
- +1 more
Jul 19, 2022
Covid19 Trial in Cairo (Remdesivir, Standard of care_1, Standard of care_2)
Completed
- Covid19
- Remdesivir
- +2 more
-
Cairo, Non-US, EgyptFaculty of Medicine Ain Shams University Research Institute- Cli
Apr 17, 2021
Severe COVID-19 Trial in Seoul (DWJ1248 with Remdesivir, Placebo with Remdesivir)
Recruiting
- Severe COVID-19
- DWJ1248 with Remdesivir
- Placebo with Remdesivir
-
Seoul, Korea, Republic ofNational Medical Center
Feb 26, 2021
Effects of Remdesivir in Treatment of Severe Covid-19 Infections
Completed
- COVID-19
- Remdesivir
-
Paris, FranceHôpital Cochin
Apr 16, 2021
Coronavirus Disease 2019 Trial in Worldwide (Remdesivir)
No longer available
- Coronavirus Disease 2019
- Remdesivir
-
San Diego, California
- +21 more
Feb 15, 2022
Remdesivir in Covid-19: Mansoura University Hospital Experience
Unknown status
- Pneumonia, Viral
- Remdesivir
-
Mansoura, Dakahliya, EgyptMansoura University Hospital
Jan 27, 2021
COVID-19 Trial in Worldwide (Remdesivir)
Recruiting
- COVID-19
- Remdesivir
-
Birmingham, Alabama
- +36 more
Aug 18, 2022